FUSION PHARMACEUTICALS

Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company located in Hamilton, Ontario, Canada focused on becoming the leader in the targeted alpha therapy field. It is a spinout of the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production centre. Fusion’s deep radiochemistry expertise presents a technology platform that can be replicated to turn internalizing antibodies that have previously demonstrated limited clinica... l efficacy into highly effective cytotoxic drugs. Fusion’s ability to link the most effective isotopes to the targeting antibody allows for the creation of optimized agents for both diagnostic imaging and radioimmunotherapy (Precision Medicine). Following positive tumor identification with the imaging agent, treatment with the antibody linked to a therapeutic isotope delivers a cytotoxic payload into the cancer cell. Fusion’s lead product candidate, FPX-01, is a precision RIT that is a product of this innovative approach. FPX-01 has been designed to internalize into targeted cancer cells and deliver a lethal and highly localized radioactive payload. The precise targeting of this radiolabeled antibody causes selective and extremely effective cytotoxicity of tumor cells at relatively low doses of radioactivity.
FUSION PHARMACEUTICALS
Industry:
Biopharma Biotechnology Clinical Trials Medical Pharmaceutical
Founded:
2014-01-01
Address:
Hamilton, Ontario, Canada
Country:
Canada
Website Url:
http://www.fusionpharma.com
Total Employee:
11+
Status:
Active
Contact:
(905) 525-9140
Total Funding:
170.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
International Society of BioProcess Technology
International Society of BioProcess Technology focuses on developing and producing biopharmaceuticals worldwide.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
2020-11-01
Board_member
Current Employees Featured
John Valliant Chief Executive Officer @ Fusion Pharmaceuticals
Chief Executive Officer
2015-12-01
Lynn Wick Executive Director Finance and Operations @ Fusion Pharmaceuticals
Executive Director Finance and Operations
2017-03-01
Eric Burak Chief Scientific Officer @ Fusion Pharmaceuticals
Chief Scientific Officer
2017-02-01
Chris Leamon Chief Scientific Officer @ Fusion Pharmaceuticals
Chief Scientific Officer
2021-11-01
James O'Leary Chief Medical Officer @ Fusion Pharmaceuticals
Chief Medical Officer
2020-03-01
Maria Stahl Chief Legal Officer @ Fusion Pharmaceuticals
Chief Legal Officer
2020-09-01
Eric S. Hoffman Senior Vice President, Business Development @ Fusion Pharmaceuticals
Senior Vice President, Business Development
2021-09-01
Founder
Stock Details
Investors List
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board investment in Venture Round - Fusion Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series B - Fusion Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Fusion Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series B - Fusion Pharmaceuticals
FACIT.com
FACIT.com investment in Series B - Fusion Pharmaceuticals
Seroba Life Sciences
Seroba Life Sciences investment in Series B - Fusion Pharmaceuticals
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series B - Fusion Pharmaceuticals
FACIT
FACIT investment in Series B - Fusion Pharmaceuticals
Varian
Varian investment in Series B - Fusion Pharmaceuticals
HealthCap
HealthCap investment in Series B - Fusion Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.fusionpharma.com Semrush global rank: 2.62 M Semrush visits lastest month: 6.62 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Fusion Pharmaceuticals"
Fusion Pharmaceuticals | Ontario Bioscience Innovation …
Fusionpharma.com. Locations. Hamilton, ON, Canada. Size. 51-200 employees. founded in. 2014. Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing …See details»
Fusion Pharmaceuticals - Crunchbase Company Profile …
Organization. Fusion Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Fusion Management - Careers - Fusion Pharma
We are a purpose-driven organization. We are rooted in science and motivated by a commitment to address unmet medical needs for cancer patients. We are a …See details»
Fusion Pharmaceuticals - LinkedIn
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.See details»
Fusion Pharmaceuticals Inc (FUSN-Q) Profile - The Globe and Mail
See the company profile for Fusion Pharmaceuticals Inc (FUSN-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Fusion Pharmaceuticals Company Profile | Management and
Www.fusionpharma.com Fusion Pharmaceuticals Profile and History Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals …See details»
Fusion Pharmaceuticals - Craft
Jun 4, 2024 Fusion Pharmaceuticals has 5 employees across 2 locations and $2.07 m in annual revenue in FY 2023. See insights on Fusion Pharmaceuticals including office locations, …See details»
Fusion Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
Mar 8, 2025 www.fusionpharma.com. Public Company | Subsidiary Company | 2014 | Canada | 100-250 | NASDAQ: FUSN | www.fusionpharma.com. Last update 08 Mar 2025. Overview. …See details»
Fusion Pharmaceuticals Inc - Company Profile - GlobalData
Website fusionpharma.com Telephone 1 289 7990891. No of Employees 113. Industry Pharmaceuticals and Healthcare. Revenue (2023) $2.1M Gain access to our ...See details»
Business Development / Alliance Manager – Boston, MA
Jan 15, 2019 Desire to be part of a team and organization where scientific and business excellence are shared values; Ability to travel up to 30% (domestic and international); work …See details»
Fusion Pharmaceuticals - Overview, News & Similar companies
Nov 17, 2024 Fusion Pharmaceuticals contact info: Phone number: (805) 383-3746 Website: www.fusionpharma.com What does Fusion Pharmaceuticals do? Fusion Pharmaceuticals is a …See details»
Fusion Pharmaceuticals Announces Appointment of Steven …
Mar 5, 2020 Boston, MA & Hamilton, ON – March 4, 2020 – Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals …See details»
Who Owns Fusion Pharmaceuticals – CanvasBusinessModel.com
Dec 19, 2024 Website: fusionpharma.com; Focus: Clinical-stage oncology company; ... and drive collaboration within the organization. Overall, the ownership of Fusion Pharmaceuticals …See details»
Fusion Pharmaceuticals Information - RocketReach
Fusionpharma.com; 3 617606XXXX; 781305XXXX; 781235XXXX; Elvis Tutu Vice President, Head of Regulatory Affairs at Fusion Pharmaceuticals Boston, MA, US View. 1 gmail.com; 2 …See details»
Acquisition of Fusion Pharmaceuticals Completed - Yahoo Finance
Jun 4, 2024 Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs), announced the successful …See details»
Fusion Pharmaceuticals Launches with a $25M USD Series A …
Fusion Pharmaceuticals is a spinout from the Centre for Probe Development and Commercialization (CPDC), an organization that Dr. John Valliant, ... info@fusionpharma.com …See details»
Fusion Pharmaceuticals Enters into Agreement to Build ...
Jun 2, 2021 HAMILTON, ON and BOSTON, June 2, 2021 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation …See details»
Working at Fusion Pharmaceuticals (Canada) - Glassdoor
Cons. Extremely toxic and bullying culture Negative behaviours are rewarded and promoted Favouritism and gossiping is encouraged High stress environment and long hours with …See details»
Fusion Pharmaceuticals Raises $105 Million in Oversubscribed …
Apr 1, 2019 For more information, please visit www.fusionpharma.com or contact info@fusionpharma.com. Contacts. Investors Fusion Pharmaceuticals Lynn Wick …See details»
Simplification for success: Rewiring the biopharma operating …
1 day ago Thirty-seven of them expect their organization to pursue a simplification effort over the next 12 months. Thirty-two respondents say they believe they need a significantly different …See details»